PHARMACYTE BIOTECH, INC. Earnings Per Share (Diluted)
PHARMACYTE BIOTECH, INC. (PMCB) reported Earnings Per Share (Diluted) of -$0.54 per share for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. earnings per share, diluted for the quarter ending 2026-07-31 was -$0.54.
- PHARMACYTE BIOTECH, INC. earnings per share, diluted for the quarter ending 2026-04-30 was -$0.41, a 124.05% decline year-over-year.
- PHARMACYTE BIOTECH, INC. earnings per share, diluted for the quarter ending 2026-01-31 was -$0.17.
- PHARMACYTE BIOTECH, INC. earnings per share, diluted for the quarter ending 2025-10-31 was -$1.24.
- PHARMACYTE BIOTECH, INC. earnings per share, diluted for fiscal 2026 was -$2.77, a 186.83% decline from fiscal 2025.
- PHARMACYTE BIOTECH, INC. earnings per share, diluted for fiscal 2025 was $3.19.
- PHARMACYTE BIOTECH, INC. earnings per share, diluted for fiscal 2024 was -$1.80.
- PHARMACYTE BIOTECH, INC. earnings per share, diluted for fiscal 2023 was -$0.22.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|
| 2026-07-31 | -$0.54 10-Q · filed 2026-09-14 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-09-14 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-09-14 | -$1.72 derived: net income ÷ weighted average shares · filed 2026-09-14 | |
| 2026-04-30 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$2.77 10-K · filed 2026-07-29 | |
| 2026-01-31 | -$0.17 10-Q · filed 2026-03-17 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-03-17 | -$2.41 10-Q · filed 2026-03-17 | -$0.44 derived: net income ÷ weighted average shares · filed 2026-09-14 | |
| 2025-10-31 | -$1.24 10-Q · filed 2025-12-18 | -$2.47 10-Q · filed 2025-12-18 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-09-14 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-09-14 | |
| 2025-07-31 | -$1.23 10-Q · filed 2026-09-14 | $0.50 derived: net income ÷ weighted average shares · filed 2026-09-14 | $0.05 derived: net income ÷ weighted average shares · filed 2026-09-14 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-09-14 | |
| 2025-04-30 | $1.71 derived: net income ÷ weighted average shares · filed 2026-07-29 | $1.26 derived: net income ÷ weighted average shares · filed 2026-07-29 | $1.01 derived: net income ÷ weighted average shares · filed 2026-07-29 | $3.19 10-K · filed 2026-07-29 | |
| 2025-01-31 | -$0.44 10-Q · filed 2026-03-17 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-03-17 | $1.67 10-Q · filed 2026-03-17 | $2.63 derived: net income ÷ weighted average shares · filed 2026-03-17 | |
| 2024-10-31 | -$0.39 10-Q · filed 2025-12-18 | $1.83 10-Q · filed 2025-12-18 | $2.93 derived: net income ÷ weighted average shares · filed 2026-03-17 | $2.79 derived: net income ÷ weighted average shares · filed 2026-03-17 | |
| 2024-07-31 | $1.90 10-Q · filed 2025-09-15 | $3.05 derived: net income ÷ weighted average shares · filed 2026-03-17 | $2.92 derived: net income ÷ weighted average shares · filed 2026-03-17 | $3.21 derived: net income ÷ weighted average shares · filed 2026-03-17 | |
| 2024-04-30 | $0.16 derived: net income ÷ weighted average shares · filed 2025-08-11 | $0.09 derived: net income ÷ weighted average shares · filed 2025-08-11 | $0.41 derived: net income ÷ weighted average shares · filed 2025-08-11 | -$1.80 10-K · filed 2025-08-11 | |
| 2024-01-31 | -$0.65 10-Q · filed 2025-03-17 | $0.25 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$1.47 10-Q · filed 2025-03-17 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-03-17 | |
| 2023-10-31 | -$0.26 10-Q · filed 2024-12-13 | -$0.85 10-Q · filed 2024-12-13 | -$0.04 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$0.09 derived: net income ÷ weighted average shares · filed 2025-03-17 | |
| 2023-07-31 | -$0.54 10-Q · filed 2024-09-17 | -$0.28 10-Q · filed 2023-09-18 | -$0.22 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$0.25 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$0.34 derived: net income ÷ weighted average shares · filed 2025-03-17 |
| 2023-04-30 | -$0.01 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$0.05 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$0.22 10-K · filed 2024-08-13 | |
| 2023-01-31 | -$0.04 10-Q · filed 2024-03-18 | -$0.13 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$0.21 10-Q · filed 2024-03-18 | -$0.27 derived: net income ÷ weighted average shares · filed 2024-03-18 | |
| 2022-10-31 | -$0.09 10-Q · filed 2023-12-15 | -$0.17 10-Q · filed 2023-12-15 | -$0.23 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$0.27 derived: net income ÷ weighted average shares · filed 2024-03-18 | |
| 2022-07-31 | -$0.07 10-Q · filed 2023-09-18 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$0.18 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$0.23 derived: net income ÷ weighted average shares · filed 2024-03-18 | |
| 2022-04-30 | -$0.07 derived: net income ÷ weighted average shares · filed 2023-07-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2023-07-31 | -$0.16 derived: net income ÷ weighted average shares · filed 2023-07-31 | -$0.27 10-K · filed 2023-07-31 | |
| 2022-01-31 | -$0.04 10-Q · filed 2023-03-16 | -$0.09 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$0.21 10-Q · filed 2023-03-16 | -$0.36 derived: net income ÷ weighted average shares · filed 2023-03-16 | |
| 2021-10-31 | -$0.06 10-Q · filed 2022-12-14 | -$0.21 10-Q · filed 2022-12-14 | -$0.43 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$0.67 derived: net income ÷ weighted average shares · filed 2023-03-16 | |
| 2021-07-31 | -$0.64 10-Q · filed 2022-09-14 | -$1.25 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.74 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$2.36 derived: net income ÷ weighted average shares · filed 2023-03-16 | |
| 2021-04-30 | -$0.61 derived: net income ÷ weighted average shares · filed 2022-07-28 | -$1.10 derived: net income ÷ weighted average shares · filed 2022-07-28 | -$1.71 derived: net income ÷ weighted average shares · filed 2022-07-28 | -$2.45 10-K · filed 2022-07-28 | |
| 2021-01-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$1.10 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$1.84 derived: net income ÷ weighted average shares · filed 2022-03-15 | $0.00 derived: net income ÷ weighted average shares · filed 2022-03-15 | |
| 2020-10-31 | -$0.62 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$1.38 derived: net income ÷ weighted average shares · filed 2021-12-14 | $0.00 derived: net income ÷ weighted average shares · filed 2022-03-15 | $0.01 derived: net income ÷ weighted average shares · filed 2022-03-15 | |
| 2020-07-31 | -$0.79 derived: net income ÷ weighted average shares · filed 2022-03-15 | $0.00 derived: net income ÷ weighted average shares · filed 2022-03-15 | $0.00 derived: net income ÷ weighted average shares · filed 2022-03-15 | $0.01 derived: net income ÷ weighted average shares · filed 2022-03-15 | |
| 2020-04-30 | $0.00 derived: net income ÷ weighted average shares · filed 2021-08-10 | $0.00 derived: net income ÷ weighted average shares · filed 2021-08-10 | $0.01 derived: net income ÷ weighted average shares · filed 2021-08-10 | -$4.23 derived: net income ÷ weighted average shares · filed 2021-08-10 | |
| 2020-01-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-03-12 | |
| 2019-10-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-12-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-12-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-12-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-12-11 | |
| 2019-07-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-09-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-09-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-09-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-09-11 | |
| 2019-04-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-08-13 | |
| 2019-01-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-13 | |
| 2018-10-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-12-23 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-13 | -$0.01 derived: net income ÷ weighted average shares · filed 2020-03-13 | |
| 2018-07-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-13 | -$0.01 derived: net income ÷ weighted average shares · filed 2020-03-13 | |
| 2018-04-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-08-13 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-08-13 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-08-13 | |
| 2018-01-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-03-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-03-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-03-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-03-14 | |
| 2017-10-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-03-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-12-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-03-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-03-14 | |
| 2017-07-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-03-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-03-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-03-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-03-14 | |
| 2017-04-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-07-20 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-07-20 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-07-20 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-07-20 | |
| 2017-01-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-03-19 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-03-19 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-03-19 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-03-19 | |
| 2016-10-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-12-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-12-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-12-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-12-14 | |
| 2016-07-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-09-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-09-13 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-09-13 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-09-13 | |
| 2016-04-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-07-27 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-07-27 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-07-27 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-07-27 | |
| 2016-01-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-07-27 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-07-27 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-03-13 | ||
| 2015-10-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-07-27 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-12-02 | |||
| 2015-07-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-07-27 | ||||
| 2015-04-30 | -$0.01 derived: net income ÷ weighted average shares · filed 2016-07-29 | ||||
| 2014-04-30 | -$0.05 derived: net income ÷ weighted average shares · filed 2016-07-29 | ||||
| 2013-04-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |